The Food and Drug administration is considering a new payment model aimed at encouraging drugmakers to develop new antibiotics.
FDA hopes new payment models would spark antibiotic drug development
The Food and Drug administration is considering a new payment model aimed at encouraging drugmakers to develop new antibiotics.